NPI: 1962888560 · GLENDALE, NY 11385 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 27,328 | $285K |
| 2020 | 40,583 | $284K |
| 2021 | 21,758 | $653K |
| 2022 | 17,175 | $576K |
| 2023 | 21,838 | $620K |
| 2024 | 17,658 | $439K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | 8,580 | 808 | $1.72M | |
| 90937 | 122,492 | 2,502 | $1.09M | |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 1,579 | 517 | $22K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,890 | 401 | $21K |
| J1756 | Injection, iron sucrose, 1 mg | 1,612 | 424 | $1K |
| A4657 | Syringe, with or without needle, each | 7,937 | 955 | $45.62 |
| J1270 | Injection, doxercalciferol, 1 mcg | 250 | 28 | $0.00 |